Treatment of chronic hepatitis B infection: An update of Swedish recommendations

• Published in: Scandinavian journal of infectious diseases Vol. 40; no. 6-7; pp. 436 - 450
• Main Authors: Lindh, Magnus, Uhnoo, Ingrid, Bläckberg, Joans, Duberg, Ann-Sofi, Friman, Stybjörn, Fischler, Björn, Karlström, Olof, Norkrans, Gunnar, Reichard, Olle, Sangfeldt, Per, Söderström, Ann, Sönnerborg, Anders, Weiland, Ola, Wejstål, Rune, Wiström, Johan
• Format: Journal Article
• Language: English
• Published: Basingstoke Informa UK Ltd 2008; Taylor & Francis
• Subjects: Adenine - analogs & derivatives; Adenine - therapeutic use; Adenine/analogs & derivatives/therapeutic use; Antiviral Agents - therapeutic use; Biological and medical sciences; Carcinoma, Hepatocellular - prevention & control; Clinical Medicine; Deoxycytidine - analogs & derivatives; Deoxycytidine - therapeutic use; Deoxycytidine/analogs & derivatives/therapeutic use; Drug Therapy, Combination; Emtricitabine; Guanine - analogs & derivatives; Guanine - therapeutic use; Guanine/analogs & derivatives/therapeutic use; Hepatitis B virus; Hepatitis B, Chronic - complications; Hepatitis B, Chronic - drug therapy; HIV Infections - complications; Human immunodeficiency virus; Human viral diseases; Humans; Immunocompromised Host; Infectious diseases; Infectious Medicine; Infektionsmedicin; Infektionssjukdomar; Interferon Alfa-2a/therapeutic use; Interferon-alpha - therapeutic use; Klinisk medicin; Lamivudine - therapeutic use; Liver Cirrhosis - prevention & control; Liver Transplantation; Medical and Health Sciences; Medical sciences; MEDICIN; Medicin och hälsovetenskap; MEDICINE; Microbiology in the medical area; Microbiology, immunology, infectious diseases; Mikrobiologi inom det medicinska området; Mikrobiologi, immunologi, infektionssjukdomar; Organophosphonates - therapeutic use; Phosphonic Acids/therapeutic use; Polyethylene Glycols - therapeutic use; Recombinant Proteins; Sweden; Tenofovir; Viral diseases; Viral hepatitis; Sweden; Europe; Infection; Viral hepatitis B; Treatment; Microbiology; Viral disease; Digestive diseases; Hepatic disease; Recommendation; Carcinoma; Hepatocellular/prevention & control; Combination; Drug Therapy; Chronic/complications/drug therapy; Hepatitis B

The main goal for treatment of chronic hepatitis B is to prevent complications such as liver cirrhosis or hepatocellular carcinoma. Knowledge from population studies of the long-term risk of chronic HBV infection, as well as the recent introduction of pegylated interferon and additional nucleoside a...